Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 911-920 of 1772 for cancer

Edit search filters
  1. A Phase 2, Multi-center, Open-label Study To Evaluate The Efficacy And Safety Of Luspatercept (ACE-536) In Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis And Anemia With And Without Red Blood Cell-Transfusion Dependence

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  2. Study Of Cabozantinib Alone Or In Combination With Atezolizumab To Subjects With Locally Advanced Or Metastatic Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Study Of DCC-3014 In Patients With Advanced Tumors And Tenosynovial Giant Cell Tumor

    Jacksonville, FL, Rochester, MN

  4. Focal Prostate Ablation Utilizing TULSA Profound System

    Rochester, MN

  5. A Study Of THE-630 In Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

    Jacksonville, FL

  6. A Study To Evaluate The Effect Of Ripretinib On The Pharmacokinetics Of A CYP2C8 Probe Substrate In Patients With Advanced GIST

    Jacksonville, FL

  7. Study Of RP-3500 With Niraparib Or Olaparib In Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. A Study Of MBG453 In Combination With Azacitidine And Venetoclax In AML Patients Unfit For Chemotherapy

    Rochester, MN

  9. STIMULUS MDS-US : Sabatolimab Added To HMA In Higher Risk MDS

    Scottsdale/Phoenix, AZ

  10. A Study To Investigate LYL797 In Adults With Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer